Search Results - "Bender, Sabine"
-
1
Secretome Signature Identifies ADAM17 as Novel Target for Radiosensitization of Non-Small Cell Lung Cancer
Published in Clinical cancer research (01-09-2016)“…Ionizing radiation (IR) induces intracellular signaling processes as part of a treatment-induced stress response. Here we investigate IR-induced ADAM17…”
Get full text
Journal Article -
2
Fenretinide Acts as Potent Radiosensitizer for Treatment of Rhabdomyosarcoma Cells
Published in Frontiers in oncology (15-06-2021)“…Fusion-positive rhabdomyosarcoma (FP-RMS) is a highly aggressive childhood malignancy which is mainly treated by conventional chemotherapy, surgery and…”
Get full text
Journal Article -
3
Rapid and sensitive identification of omicron by variant-specific PCR and nanopore sequencing: paradigm for diagnostics of emerging SARS-CoV-2 variants
Published in Medical microbiology and immunology (01-02-2022)“…On November 26, 2021, the World Health Organization classified B.1.1.529 as a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern…”
Get full text
Journal Article -
4
The hypoxia-activated prodrug evofosfamide in combination with multiple regimens of radiotherapy
Published in Oncotarget (04-04-2017)“…The promising treatment combination of ionizing radiation (IR) with a hypoxia-activated prodrug (HAP) is based on biological cooperation. Here we investigated…”
Get full text
Journal Article -
5
An MRAS, SHOC2, and SCRIB Complex Coordinates ERK Pathway Activation with Polarity and Tumorigenic Growth
Published in Molecular cell (12-12-2013)“…SHOC2 is mutated in Noonan syndrome and plays a key role in the activation of the ERK-MAPK pathway, which is upregulated in the majority of human cancers…”
Get full text
Journal Article -
6
Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study
Published in Radiotherapy and oncology (01-09-2020)“…•Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab did not improve the 2-year locoregional control (LRC) rate.•Toxicity was similar…”
Get full text
Journal Article -
7
The ADAM17-directed Inhibitory Antibody MEDI3622 Antagonizes Radiotherapy-induced VEGF Release and Sensitizes Non-Small Cell Lung Cancer for Radiotherapy
Published in Cancer research communications (01-12-2021)“…The cellular response to ionizing radiation (IR) depends on tumor cell and microenvironmental factors. Here, we investigated the role of IR-induced ADAM17…”
Get full text
Journal Article -
8
Combined treatment strategies for microtubule stabilizing agent-resistant tumors
Published in JNCI : Journal of the National Cancer Institute (01-04-2015)“…Resistance to microtubule-stabilizing agents is a major hurdle for successful cancer therapy. We investigated combined treatment of microtubule-stabilizing…”
Get full text
Journal Article -
9
Genomic epidemiology reveals multiple introductions of SARS-CoV-2 followed by community and nosocomial spread, Germany, February to May 2020
Published in Euro surveillance : bulletin européen sur les maladies transmissibles (28-10-2021)“…Background In the SARS-CoV-2 pandemic, viral genomes are available at unprecedented speed, but spatio-temporal bias in genome sequence sampling precludes…”
Get full text
Journal Article -
10
Automated antigen assays display a high heterogeneity for the detection of SARS-CoV-2 variants of concern, including several Omicron sublineages
Published in Medical microbiology and immunology (01-10-2023)“…Diagnostic tests for direct pathogen detection have been instrumental to contain the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2)…”
Get full text
Journal Article -
11
Abstract C145: Targeted radiosensitization of non-small cell lung cancer (NSCLC) through ADAM17 inhibition
Published in Molecular cancer therapeutics (01-12-2015)“…Abstract Introduction: Radiotherapy is a mainstay for the treatment of locally advanced NSCLC. However, the response rates and clinical outcomes are still…”
Get full text
Journal Article -
12
Abstract A185: Combined treatment strategies for microtubule interfering agent-resistant tumors
Published in Molecular cancer therapeutics (01-12-2015)“…Abstract Treatment resistances to specific anticancer agents and radiotherapy are often linked to the mutated genetic background of tumor cells. Their…”
Get full text
Journal Article -
13
Abstract 4045: MRAS and SHOC2 interact with SCRIB and coordinate ERK pathway activation with polarity and tumorigenic growth
Published in Cancer research (Chicago, Ill.) (01-08-2015)“…Abstract SHOC2 is mutated in Noonan syndrome and plays a key role in the activation of the ERK-MAPK pathway, which is upregulated in the majority of human…”
Get full text
Journal Article -
14
Abstract A22: An MRAS, SHOC2, and SCRIB complex coordinates ERK pathway activation with polarity and tumorigenic growth
Published in Molecular cancer research (01-12-2014)“…Abstract SHOC2 is mutated in Noonan syndrome and plays a key role in the activation of the ERK-MAPK pathway, which is upregulated in the majority of human…”
Get full text
Journal Article -
15
Methodical influence on selected parameters of the acid-base equilibrium in urine samples from dairy cows
Published in Berliner und Münchener tierärztliche Wochenschrift (01-09-2003)“…Estimation of net acid base excretion (NABE) in urine samples of dairy cows has often been reported in the veterinary literature. NABE has been proved to be…”
Get more information
Journal Article